Here, we describe how CD8 T cells, CD4 T cells, regulatory T cells, TCR repertoire and the neutrophils-to-lymphocytes ratio (NLR) affect ICI response in NSCLC patients. This evidence concerns the gene CD4 and non-small cell lung carcinoma.